Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Organ Transplant Med ; 3(1): 26-31, 2012.
Article in English | MEDLINE | ID: mdl-25013620

ABSTRACT

BACKGROUND: The gold standard for investigating the cause of renal graft dysfunction is renal biopsy. However, as this procedure is invasive and has inherent risks, its safety must be established. OBJECTIVE: To determine the safety of percutaneous renal biopsy in pediatric orthotopic renal transplantation. METHODS: Percutaneous renal biopsies performed on pediatric orthotopic renal transplants in a single center between 1987 and 2010 were studied. Biopsy specimen adequacy and post-procedure complications were reviewed by prospectively collected data. RESULTS: A total of 54 ultrasound "real-time" guided biopsies in 25 patients were performed. Minimum specimen adequacy was achieved in 98% of biopsy specimens. No major complications were identified; 6% of patients developed minor complications-e.g., grade 3 macroscopic hematuria that did not require intervention. CONCLUSION: Percutaneous renal biopsies using "real-time" ultrasound guidance on pediatric orthotopic kidney transplants is safe.

2.
Int Surg ; 93(5): 274-7, 2008.
Article in English | MEDLINE | ID: mdl-19943429

ABSTRACT

Previous studies suggest that surgical treatment of metastatic melanoma in carefully selected patients does improve survival. This paper assesses the survival of melanoma patients with hepatic metastases who underwent surgery in our unit. Fifteen (0.64%) patients had hepatic melanoma metastases. Seven patients underwent curative surgery. Surgical intervention included curative as well as palliative control of hepatic disease. Overall survival was calculated by the Kaplan-Meier method. Median survival for the 15 patients was 7 months. Median survival time in the curative surgical group and the palliative/nonsurgical group was 22 and 6 months, respectively. Patients with ocular primary, single lesions, and unilobar disease had a better outcome. Those who were selected and underwent surgery had a better overall survival compared with patients who are treated nonoperatively. Resection of hepatic melanoma metastases has a role in selected patients.


Subject(s)
Cryotherapy , Hepatectomy , Liver Neoplasms/surgery , Melanoma/surgery , Aged , Combined Modality Therapy , Female , Humans , Liver Neoplasms/secondary , Male , Melanoma/pathology , Middle Aged , Prognosis , Survival Analysis
3.
Transplant Proc ; 38(6): 1733-4, 2006.
Article in English | MEDLINE | ID: mdl-16908265

ABSTRACT

INTRODUCTION: Following intestinal transplant (SBT), the early diagnosis and treatment of rejection is a major management aim. The diagnosis of rejection is based on histology of stomal biopsies. Oral gentamycin (2.5 mg/kg) was used for selective decontamination of the digestive system. Our hypothesis was that gentamycin might be absorbed in the presence of graft dysfunction. AIM: Our goal was to assess the correlation between serum gentamycin level and the health of the intestinal graft. SUBJECTS AND METHODS: Among 33 SBT performed from 1993 to 2005, serum gentamycin levels were performed once weekly or more often when there was a suspicion of rejection. All data were analyzed retrospectively. RESULTS: Adequate trough levels were achieved for only 23 patients, six of whom had histologically proven rejection and only one did not have a raised gentamycin content. Five patients with raised levels but no rejection included two with severe intestinal ischemia and three with bowel obstruction/ileus. Four of the five patients required laparotomies. CONCLUSION: We concluded that in our study raised serum gentamycin levels were a good predictor of rejection or significant injury to the graft.


Subject(s)
Biomarkers/blood , Gentamicins/blood , Graft Rejection/diagnosis , Intestine, Small/injuries , Intestine, Small/transplantation , Transplantation, Homologous/pathology , Child, Preschool , Female , Graft Rejection/blood , Humans , Intestinal Diseases/classification , Intestinal Diseases/surgery , Male , Reproducibility of Results , Retrospective Studies
4.
Transplant Proc ; 36(8): 2466-8, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15561283

ABSTRACT

INTRODUCTION: The most effective treatment for acute or chronic liver failure is orthotopic liver transplantation. Worldwide there is a shortage of organs for transplantation. This shortage has called for research into new treatments for management of patients with liver failure. One such treatment is hepatocyte transplantation. During liver resections considerable amounts of normal liver are unavoidably resected. We aim to harvest these hepatocytes and to filter the tumor cells from them to provide a source for transplantation. MATERIALS AND METHODS: After liver resection, the largest vessel at the resected liver edge was identified and cannulated. Seglen's two-stage technique of perfusing the liver with EDTA and collagenase was performed to harvest the hepatocytes. Ep-CAM Ags are consistently present on the surface of epithelial cells and in particular in colorectal cancer cells. Therefore, MOC31 antibodies (selective Abs for Ep-CAM) attached to magnetic beads were used to target the tumor cells. These tumor cells are selectively removed using a magnet. CEA staining was then used to ensure the hepatocyte collection was tumor cell free. Five million hepatocytes were rosetted with one million HT29 CRC cells to assess the immunomagnetic filtration technique. RESULTS: The hepatocyte harvesting resulted in 864,000 viable hepatocytes to be harvested per gram of liver. Histochemical staining using CEA demonstrated 75% of the HT29 cells in the hepatocyte collection were removed after one use of magnetic beads. CONCLUSION: We have demonstrated the successful initial stages of harvesting tumor-free hepatocytes from liver resected for malignancy.


Subject(s)
Hepatocytes/transplantation , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Aged , Carcinoembryonic Antigen/analysis , Colorectal Neoplasms/pathology , Female , Hepatectomy/methods , Hepatocytes/pathology , Humans , Immunomagnetic Separation , Liver Neoplasms/pathology , Male , Middle Aged , Tissue and Organ Harvesting/methods
7.
Aust N Z J Surg ; 68(10): 698-701, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9768604

ABSTRACT

BACKGROUND: Microvascular free-tissue transfer is now the primary method of reconstruction in many centres. The aim of this study was to evaluate the applications, complications and limitations of free-flap reconstruction in a series of patients with tumours of the head and neck. METHODS: This study reviewed prospectively accessioned computerized records in a dedicated head and neck database. Patients treated between 1987 and 1995 with a minimum of a 1-year follow-up were reviewed. There were 242 patients with a mean age of 58 years (172 men and 70 women). The most common tumour sites were oral cavity (42%), oropharynx (32%) and hypopharynx (11%). Mucosal squamous carcinoma accounted for 87% of primary cancers. RESULTS: Among the 250 free flaps, the radial forearm flap (205) and free jejunum (25) predominated. There were 21 episodes of vascular occlusion (8%), failure of 10 flaps (4%) and two patients died peri-operatively (0.8%). A second free flap was used in five of 10 cases of flap failure. The fistula rate was 4.4% among 203 patients at risk for this complication, which comprised four of 178 forearm flaps and five of 25 free jejunal grafts. Four of 16 jaw reconstructions failed. CONCLUSIONS: A 96% success rate was achieved using free-tissue transfer for head and neck reconstruction. The overall complication rate was low but jaw reconstruction and free jejunal grafts posed the greatest problems because of failure of radial bone and fistulas, respectively. The radial forearm septocutaneous flap was very reliable and remains our mainstay for oral reconstruction.


Subject(s)
Head and Neck Neoplasms/surgery , Plastic Surgery Procedures , Surgical Flaps , Adult , Aged , Aged, 80 and over , Carcinoma, Basal Cell/surgery , Carcinoma, Squamous Cell/surgery , Female , Humans , Hypopharynx , Male , Middle Aged , Mouth Neoplasms/surgery , Oropharynx , Pharyngeal Neoplasms/surgery , Postoperative Complications/epidemiology , Prospective Studies , Treatment Failure
SELECTION OF CITATIONS
SEARCH DETAIL
...